# Paradigm4

> Paradigm4 builds scientific data management and analytics software for the life sciences. Its flagship REVEAL platform and SciDB array database let pharma, biotech, and research institutions integrate and analyze massive multimodal datasets - genomics, multi-omics, imaging, clinical records, wearables, and environmental data - to find biomarkers and validate drug targets. Co-founded in 2010 by entrepreneur Marilyn Matz and Turing Award-winning MIT professor Michael Stonebraker, the company is based in Waltham, Massachusetts.

- **Founded:** 2010
- **Headquarters:** Waltham, Massachusetts, United States
- **Founders:** Marilyn Matz (CEO & Co-founder), Michael Stonebraker (CTO & Co-founder)
- **Team size:** Approximately 28 employees
- **Products:** REVEAL, SciDB, flexFS, Trusted Research Environment (TRE), Tech-Enabled Services
- **Notable:** Built SciDB, the array database that powered the NIH NCBI 1000 Genomes browser, Co-founded by Turing Award winner Michael Stonebraker, Adopted by leading pharma including Amgen, Janssen, Alnylam, and Bristol Myers Squibb

## Products & services

- **REVEAL** — Multimodal evidence and translational informatics platform with the PheGe Browser, enabling integrative, longitudinal, population-scale analysis of multi-omics, clinical, behavioral, imaging, and environmental data for biomarker-guided drug discovery.
- **SciDB** — A massively parallel, transaction-safe, array-oriented database and computational engine that models data as multidimensional arrays, allowing linear-algebra and machine-learning tools to run efficiently on huge scientific datasets.
- **flexFS** — A data management and file system solution for handling large scientific datasets at scale.
- **Trusted Research Environment (TRE)** — Secure, compliant infrastructure for hosting sensitive research data and collaborative analysis.
- **Tech-Enabled Services** — Implementation, bioinformatics, and support services that help customers operationalize multimodal data analysis.

## Achievements

- Built SciDB, the array database that powered the NIH NCBI 1000 Genomes browser
- Co-founded by Turing Award winner Michael Stonebraker
- Adopted by leading pharma including Amgen, Janssen, Alnylam, and Bristol Myers Squibb
- Launched a precision medicine platform for UK Biobank data with industry-leading adopters (2018)
- Pivoted into single-cell data analysis and helped pharma respond to COVID-19 (2020)

## Latest updates

- **2020-04** — Profiled by MIT News for accelerating data-driven discoveries in pharma and biotech.
- **2020-01** — Moved into single-cell data analysis and helped pharma address COVID-19 research needs.
- **2018-11** — Launched precision medicine platform for UK Biobank data and announced industry-leading adopters.

## Links

- Website: https://paradigm4.com
- LinkedIn: https://www.linkedin.com/company/paradigm4
- Twitter/X: https://twitter.com/paradigm4
- GitHub: https://github.com/Paradigm4
- YouTube: https://www.youtube.com/user/paradigm4inc
- Facebook: https://facebook.com/paradigm4

---

Profile page: https://yespress.io/paradigm4
Published by YesPress — https://yespress.io
Last updated: 2026-06-08